DataMeds AI, Inc. (MEDS)
1.16
-0.06
(-4.92%)
USD |
NASDAQ |
Nov 06, 10:23
DataMeds AI EPS Diluted (Quarterly) : -7.132 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.132 |
| March 31, 2026 | -3.242 |
| December 31, 2025 | -13.75 |
| September 30, 2025 | -19.18 |
| June 30, 2025 | -5.284 |
| March 31, 2025 | -26.38 |
| December 31, 2024 | -4.170 |
| Date | Value |
|---|---|
| September 30, 2024 | -1.797 |
| June 30, 2024 | -0.553 |
| March 31, 2024 | -0.08 |
| December 31, 2023 | -1.036 |
| September 30, 2023 | -0.8695 |
| June 30, 2023 | -0.4125 |
| March 31, 2023 | -0.469 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -0.0001 |
| Xcelerate, Inc. | -0.0001 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0004 |
| Vivos Therapeutics, Inc. | -0.31 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.36M |
| Revenue (Quarterly) | 1.780M |
| Total Expenses (Quarterly) | 20.14M |
| Enterprise Value | 33.79M |
| Gross Profit Margin (Quarterly) | -9.80% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -3.73K% |
| Normalized Earnings Yield | -3037.44 |